Valuation (86%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 9.87 | N/A |
| PEG Ratio (TTM) | -0.28 | N/A |
| P/S Ratio (TTM) | 0.70 | N/A |
| P/B Ratio (TTM) | 0.99 | N/A |
| P/FCF Ratio (TTM) | 1.53 | N/A |
| Price to 5YR AVG Earnings Ratio | 5.88 | N/A |
| Price to 5YR AVG FCF Ratio | 1.89 | N/A |
Profitability (30%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 1.44% | N/A |
| ROE (TTM) | 10.20% | N/A |
| Net Profit Margin (TTM) | 7.07% | N/A |
| ROIC 5YR AVG | 14.15% | N/A |
Growth (52%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 9.31% | 26.81% | 46.15% |
| Revenue | -0.26% | -16.04% | -10.16% |
| Net Income | 9.38% | 27.50% | 46.46% |
| Cash Flow | -6.79% | -6.41% | 1.61% |
Health (39%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | N/A | N/A |
| Quick Ratio (TTM) | N/A | N/A |
| D/E Ratio (TTM) | 1.47 | N/A |
| Interest Coverage (TTM) | 0.02 | N/A |
| Piotroski F-Score | 6 | N/A |
| Altman Z-Score | 0.77 | N/A |
| LTL to 5YR AVG FCF | 3.35 | N/A |
| Shares Outstanding Growth 5YR AVG | -1.83% | N/A |